During the past decade, Kaiser Permanente - Denver conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 11 clinical trials were completed, i.e. on average, 550% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente - Denver" #1 sponsor was "SWOG Cancer Research Network" with 6 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente - Denver" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Community Programs for Clinical Research on AIDS" with 2 trials as a collaborator, "Kaiser Permanente" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Aptuit" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente - Denver" are "HIV Infections" (5 trials), "Colorectal Cancer" (4 trials), "Breast Cancer" (3 trials), "Lung Cancer" (3 trials) and "Neurotoxicity" (3 trials). Many other conditions were trialed in "Kaiser Permanente - Denver" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente - Denver" are "Drug" (12 trials), "Other" (8 trials), "Biological" (7 trials), "Behavioral" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (5 trials), "bevacizumab" (3 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (2 trials) and "laboratory biomarker analysis" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente - Denver" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente - Denver". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Kaiser Permanente - Denver, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente - Denver, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".